Sonoma Pharmaceuticals (SNOA) Finished Goods (2012 - 2025)

Sonoma Pharmaceuticals' Finished Goods history runs 13 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• In Q4 2025, Finished Goods fell 2.74% year-over-year to $2.0 million; the TTM figure through Dec 2025 stood at $2.0 million (down 2.74% YoY), while the FY2025 annual figure was $1.8 million, up 49.88% from the prior year.
• Finished Goods was $2.0 million for Q4 2025 at Sonoma Pharmaceuticals, down from $2.0 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $2.4 million in Q2 2025 to a low of $773000.0 in Q3 2021.
• Historically, Finished Goods has averaged $1.4 million across 5 years, with a median of $1.2 million in 2021.
• The sharpest annual moves came in 2021 and 2025: Finished Goods sank 51.87% in 2021, then surged 91.92% in 2025.
• A 5-year view of Finished Goods shows it stood at $1.3 million in 2021, then fell by 1.12% to $1.2 million in 2022, then climbed by 16.96% to $1.4 million in 2023, then jumped by 38.54% to $2.0 million in 2024, then dropped by 2.74% to $2.0 million in 2025.
• The last three Finished Goods figures came in at $2.0 million (Q4 2025), $2.0 million (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.